Morgan Stanley analyst David Lewis noted that Intuitive Surgical's System average selling prices recovered in Q2 and its procedures came in above consensus, stating that he thinks the report should put the "mix debate to bed." Guidance implies stability into the back half of the year and "does not appear aggressive," said Lewis, who also thinks the consensus view on system placements looks conservative in the second half. He keeps an Overweight rating and $620 price target on Intuitive Surgical shares.

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here

Check out this morning's top movers from around Wall Street, compiled by The Fly.  HIGHER - Paramount (PARA)... To see the rest of the story go to thefly.com. See Story Here

Piper Sandler raised the firm's price target on Intuitive Surgical to $435 from $425 and keeps an Overweight rating on the shares. The company reported Q1 results that topped consensus on both the top- and bottom-line, the analyst tells investors in a research note. The firm says there were several positive operational updates announced on the earnings call, such as, healthy initial demand for SP in Europe and Chinese regulatory approval for Ion. The Q1 report had "little-to-nothing to pick at," contends Piper. Intuitive remains its favorite large-cap medtech name.

Check out this evening's top movers from around Wall Street, compiled by The Fly. HIGHER AFTER EARNINGSMetropolitan... To see the rest of the story go to thefly.com. See Story Here

Sees FY24 gross profit margin 67%-68%. Sees FY24 operating expense up 11%-15%. Sees FY24 capital expenditures 1B-$1.2B. Sees FY24 tax rate 22%-24%. Says five additional procedures will have reimbursement in Japan by June. Says saw particular strength in the U.S. and the U.K. Comments and guidance taken from Q1 earnings conference call.

Pre-earnings options volume in Intuitive Surgical is 2.0x normal with calls leading puts 10:9. Implied volatility suggests the market is anticipating a move near 4.9%, or $18.11, after results are released. Median move over the past eight quarters is 5.6%.